Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-19

Clinical Trial Update: Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial in young patients with newly diagnosed nasopharyngeal cancer evaluating radiation therapy, amifostine, and chemotherapy has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amifostine (amifostine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7 | Phase 3 | Status: COMPLETED | Results posted: 2017-01-19